Public Health England Guidance – COVID-19: the green book, chapter 14a
The COVID-19 vaccine communication handbook – a practical guide for improving vaccine communication and fighting misinformation.
The National Institute for Health Research provides information about ongoing coronavirus vaccine research.
E-learning for Healthcare: COVID-19 Vaccination.
E-learning designed to help staff promote and deliver COVID-19 vaccines.
Independent SAGE – New statements on the UK vaccine strategy.
Royal College of Nursing – COVID-19 vaccination.
UK Government: COVID-19 vaccination programme. A collection of documents related to COVID-19 vaccination.
BMJ Best Practice – COVID -19 Vaccine information
New England Journal of Medicine – Covid-19 Vaccine Resource Center
NIHR Oxford Health Biomedical Research Centre, Oxford Precision Psychiatry Lab – Vaccine uptake and vaccine hesitancy
Pfizer-BioNTech COVID-19 vaccine (BNT162b2 mRNA Covid-19 vaccine)
- Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine, The New England Journal of Medicine, 2020, December 10
- Vaccines and Related Biological Products Advisory Committee Meeting, FDA Briefing Document: Pfizer-BioNTech COVID-19 vaccine.US Food and Drug Administration. December 10, 2020
- Vaccinating the UK: how the covid vaccine was approved, and other questions answered, BMJ 2020;371:m4759. (Published 09 December 2020)
Pfizer Phase 3 Trial registry data
Oxford vaccine (ChAdOx1 nCoV-19 vaccine (AZD1222)
- Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK. The Lancet, 2020, December 08.
- Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial – Lancet 20 Jul 2020
- Oxford AstraZeneca Phase 3 Trial registry data
Moderna Vaccine(mRNA-1273 COVID-19 vaccine)
Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine
New England Journal of Medicine, 2020, December 30
Safety and immunogenicity of SARS-CoV-2 mRNA-1273 vaccine in older adults
New England Journal of Medicine, 2020, December 17
An mRNA Vaccine against SARS-CoV-2 — preliminary report.
New England Journal of Medicine, 2020, November 2020
Ad26.COV2.S vaccine (Johnson & Johnson)
Interim results of a phase 1–2a trial of Ad26.COV2.S Covid-19 vaccine
Sadoff J, Le Gars M, Shukarev G, Heerwegh D, Truyers C, et al.
New England Journal of Medicine, 2021, January 13
Gam-COVID-Vac (Sputnik V)
Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia
Logunov DY, Dolzhikova IV, Shcheblyakov DV, Tukhvatulin AI, Zubkova, OV, et al.
Lancet, 2021. February 02